1022 related articles for article (PubMed ID: 32358041)
61. Fcγ receptor deficiency attenuates diabetic nephropathy.
Lopez-Parra V; Mallavia B; Lopez-Franco O; Ortiz-Muñoz G; Oguiza A; Recio C; Blanco J; Nimmerjahn F; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2012 Sep; 23(9):1518-27. PubMed ID: 22859852
[TBL] [Abstract][Full Text] [Related]
62. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Feng QQ; Ojo OO; Wang XH
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
[TBL] [Abstract][Full Text] [Related]
63. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
Front Immunol; 2021; 12():753287. PubMed ID: 34777363
[TBL] [Abstract][Full Text] [Related]
64. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
65. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
[TBL] [Abstract][Full Text] [Related]
66. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in
Han X; Wang Y; Zhang P; Zhu M; Li L; Mao X; Sha X; Li L
Pharm Biol; 2021 Dec; 59(1):1077-1087. PubMed ID: 34392792
[TBL] [Abstract][Full Text] [Related]
67. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
68. Dietary fiber of Tartary buckwheat bran modified by steam explosion alleviates hyperglycemia and modulates gut microbiota in db/db mice.
He X; Li W; Chen Y; Lei L; Li F; Zhao J; Zeng K; Ming J
Food Res Int; 2022 Jul; 157():111386. PubMed ID: 35761642
[TBL] [Abstract][Full Text] [Related]
69. Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer's Disease.
Zhou Y; Xie L; Schröder J; Schuster IS; Nakai M; Sun G; Sun YBY; Mariño E; Degli-Esposti MA; Marques FZ; Grubman A; Polo JM; Mackay CR
J Neurosci; 2023 Sep; 43(37):6460-6475. PubMed ID: 37596052
[TBL] [Abstract][Full Text] [Related]
70. Effects of Oat Fiber Intervention on Cognitive Behavior in LDLR
Gao H; Song R; Li Y; Zhang W; Wan Z; Wang Y; Zhang H; Han S
J Agric Food Chem; 2020 Dec; 68(49):14480-14491. PubMed ID: 33237770
[TBL] [Abstract][Full Text] [Related]
71. [Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota].
Kimura I
Yakugaku Zasshi; 2014; 134(10):1037-42. PubMed ID: 25274213
[TBL] [Abstract][Full Text] [Related]
72. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
[TBL] [Abstract][Full Text] [Related]
73. Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
Kundi ZM; Lee JC; Pihlajamäki J; Chan CB; Leung KS; So SSY; Nordlund E; Kolehmainen M; El-Nezami H
Mol Nutr Food Res; 2021 Jan; 65(1):e1900580. PubMed ID: 32526796
[TBL] [Abstract][Full Text] [Related]
74. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
Zhang Q; Xiao X; Zheng J; Li M; Yu M; Ping F; Wang T; Wang X
Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
[TBL] [Abstract][Full Text] [Related]
75. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
76. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
77. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.
Docampo MD; da Silva MB; Lazrak A; Nichols KB; Lieberman SR; Slingerland AE; Armijo GK; Shono Y; Nguyen C; Monette S; Dwomoh E; Lee N; Geary CD; Perobelli SM; Smith M; Markey KA; Vardhana SA; Kousa AI; Zamir E; Greenfield I; Sun JC; Cross JR; Peled JU; Jenq RR; Stein-Thoeringer CK; van den Brink MRM
Blood; 2022 Apr; 139(15):2392-2405. PubMed ID: 34653248
[TBL] [Abstract][Full Text] [Related]
78. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Int J Biol Sci; 2022; 18(1):96-111. PubMed ID: 34975320
[No Abstract] [Full Text] [Related]
79. Gut modulation based anti-diabetic effects of carboxymethylated wheat bran dietary fiber in high-fat diet/streptozotocin-induced diabetic mice and their potential mechanisms.
Li XX; Zhang XX; Zhang R; Ni ZJ; Elam E; Thakur K; Cespedes-Acuña CL; Zhang JG; Wei ZJ
Food Chem Toxicol; 2021 Jun; 152():112235. PubMed ID: 33894295
[TBL] [Abstract][Full Text] [Related]
80. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
